Multiple sclerosis and drug discovery: A work of translation

Multiple sclerosis (MS) is after trauma the most important neurological disease in young adults, affecting 1 per 1000 individuals. With currently available medications, most of these targeting the immune system, satisfactory results have been obtained in patients with relapsing MS, but these can hav...

Descripción completa

Detalles Bibliográficos
Autores principales: ’t Hart, Bert A., Luchicchi, Antonio, Schenk, Geert J, Killestein, Joep, Geurts, Jeroen J.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245896/
https://www.ncbi.nlm.nih.gov/pubmed/34044219
http://dx.doi.org/10.1016/j.ebiom.2021.103392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245896/
https://www.ncbi.nlm.nih.gov/pubmed/34044219
http://dx.doi.org/10.1016/j.ebiom.2021.103392

Ejemplares similares